Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

Imatinib remains the best frontline therapy in patients with chronic myeloid leukemia: Critical analysis of the ASC4FIRST trial

Published Web Location

https://doi.org/10.1002/ajh.27477Creative Commons 'BY' version 4.0 license
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View